CAT vs DNTH · P/E 48, rev $20.54B vs rev $6.2M
Caterpillar Inc (CAT) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported CAT revenue for 2026-06-30 was $20.54B. Net income was $3.59B. Revenue was up 18.0% from 2026-03-31 to 2026-06-30. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the CAT and DNTH stock pages for the full models.
Not investment advice.